Skip to main content
SpringerLink
Log in

Estado actual del diagnóstico y tratamiento del hepatoblastoma

  • Educational Review
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliografía

  1. Ross JA, Gurney JG. Hepatoblastoma incidence in the United States from 1973 to 1992. Med Pediatr Oncol. 1998;30:141–2.

    Article  PubMed  CAS  Google Scholar 

  2. Tanimura M, Matsui I, Abe J, et al. Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res. 1998;58:3032–5.

    PubMed  CAS  Google Scholar 

  3. Ikeda H, Matsuyama S, Tanimura M. Association between hepatoblastoma and very low birth weight: a trend or a chance?. J Pediatr. 1997;130:557–60.

    Article  PubMed  CAS  Google Scholar 

  4. Kapfer SA Petruzzi MJ, Caty MG. Hepatoblastoma in low birth weight infants: an institutional review. Pediatr Surg Int. 2004:753–6.

  5. Cetta F, Montalto G, Petracci M. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut. 1997;41:417.

    Article  PubMed  CAS  Google Scholar 

  6. Montalto G, Cetta F, Baldi C, et al. Wide range of primary liver tumors can be found in patients with familial adenomatous polyposis. J Pediatr Hematol Oncol. 2000;22:90–1.

    Article  PubMed  CAS  Google Scholar 

  7. Giardiello FM, Petersen GM, Brensinger JD, et al. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut. 1996;39:867–9.

    Article  PubMed  CAS  Google Scholar 

  8. Toguchida J., Yamaguchi T, Dayton SH, et al. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med. 1992; 326:1301–8.

    Article  PubMed  CAS  Google Scholar 

  9. Hamada Y, Takada K, Fukunaga S, Hioki K. Hepatoblastoma associated with Beck with-Wiedemann syndrome and hemihypertrophy. Pediatr Surg Int. 2003;19:112–4.

    PubMed  CAS  Google Scholar 

  10. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiede-mann Syndrome Registry. J Pediatr. 1998;132:398–400.

    Article  PubMed  CAS  Google Scholar 

  11. Vaughan WG, Sanders DW, Grosfeld JL, et al. Favorable outcome in children with Beckwith-Wiedemann syndrome and intraabdominal malignant tumors. J Pediatr Surg. 1995;30:1042–4; discussion 1044–5.

    Article  PubMed  CAS  Google Scholar 

  12. Clericuzio CL, Chen E, McNeil DE, et al. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr. 2003;143:270–2.

    Article  PubMed  Google Scholar 

  13. Vos A. Primary liver tumours in children. Eur J Surg Oncol. 1995;21:101–5.

    Article  PubMed  CAS  Google Scholar 

  14. Rowland JM. Hepatoblastoma: assessment of criteria for histologic classification. Med Pediatr Oncol. 2002;39:478–83.

    Article  PubMed  Google Scholar 

  15. Zimmermann A. Hepatoblastoma with cholangioblastic features (‘cholangioblastic hepatoblastoma’) and other liver tumors with bimodal differentiation in young patients. Med Pediatr Oncol. 2002;39:487–91.

    Article  PubMed  Google Scholar 

  16. Surace C, Leszl A, Perilongo G, et al. Fluorescent in situ hybridization (FISH) reveals frequent and recurrent numerical and structural abnormalities in hepatoblastoma with no informative karyotype. Med Pediatr Oncol. 2002: 39:536–9.

    Article  PubMed  CAS  Google Scholar 

  17. Parada LA, Limon J, Iliszko M, et al. Cytogenetics of hepatoblastoma: further characterization of 1q rearrangements by fluorescence in situ hybridization: an international collaborative study. Med Pediatr Oncol. 2000;34:165–70.

    Article  PubMed  CAS  Google Scholar 

  18. Buendia MA. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Med Pediatr Oncol. 2002;39:530–5.

    Article  PubMed  Google Scholar 

  19. Koch A, Denkhaus D, Albrecht S, et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res. 1999; 59:269–73.

    PubMed  CAS  Google Scholar 

  20. Yamaguchi H, Ishii E, Hayashida Y, et al. Mechanism of thrombocytosis in hepatoblastoma: a case report. Pediatr Hematol Oncol. 1996;13:539–44.

    PubMed  CAS  Google Scholar 

  21. Komura E, Matsumura T, Kato T, et al. Thrombopoietin in patients with hepatoblastoma. Stem Cells. 1998;16:329–33.

    Article  PubMed  CAS  Google Scholar 

  22. Begemann M, Trippett TM, Lis E, Antunes NL. Brain metastases in hepatoblastoma. Pediatr Neurol. 2004;30:295–7.

    Article  PubMed  Google Scholar 

  23. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma-results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer. 2000;36:1418–25.

    Article  PubMed  CAS  Google Scholar 

  24. Plaschkes J editor. “Proceedings of an international research workshop on pediatric liver tumours, 18–20 March 1999, Berne, Switzerland. Into the year 2000;2001

  25. Aronson DC, Schnater JM, Staalman CR, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol. 2005;23:1245–52.

    Article  PubMed  Google Scholar 

  26. Perilongo G, Shafford E, Maibach R, et al. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2. Eur J Cancer. 2004;40:411–21.

    Article  PubMed  CAS  Google Scholar 

  27. Evans AE, Land VJ, Newton WA, et al. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer. 1982;50:821–6.

    Article  PubMed  CAS  Google Scholar 

  28. Douglass EC, Green AA, Wrenn E, et al. Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol. 1985;13:187–90.

    Article  PubMed  CAS  Google Scholar 

  29. Ortega JA, Krailo MD, Haas JE, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J Clin Oncol. 1991;9:2167–76.

    PubMed  CAS  Google Scholar 

  30. Perilongo G, Shafford E, JP, et al. Treatment outcome of metastatic HB—Preliminary report of the SIOPEL-1 Study. Med Ped Oncol. 1994;23.

  31. Plaschkes J, Perilongo G, Shafford E, et al. Preoperative chemotherapy PLADO for the treatment of Hepatoblastoma and Hepatocellular carcinoma. Results after two years follow up. Med Ped Oncol. 1996;27:256.

    Google Scholar 

  32. Perilongo G, Dall'Igna P, Sainati L. Modern treatment of childhood hepatoblastoma: what do clinicians and pathologists have to say to each other? Med Pediatr Oncol. 2003;39:474–7.

    Article  Google Scholar 

  33. Finegold MJ. Chemotherapy for suspected hepatoblastoma without efforts at surgical resection is a bad practice. Med Pediatr Oncol. 2002;39:484–6.

    Article  PubMed  Google Scholar 

  34. Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol. 2000;18:2665–75.

    PubMed  CAS  Google Scholar 

  35. Blouin P, Brugieres L, Tabone MD, et al. Carboplatin-epirubicin regimen for the treatment of hepatoblastoma. Pediatr Blood Cancer. 2004;42:149–54.

    Article  PubMed  CAS  Google Scholar 

  36. Sasaki F, Matsunaga T, Iwafuchi M, et al. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg. 2002;37:851–6.

    Article  PubMed  CAS  Google Scholar 

  37. Palmer RD, Williams DM. Dramatic response of multiply relapsed hepatoblastoma to irinotecan, (CPT-11). Med Pediatr Oncol. 2003;41:78–80.

    Article  PubMed  Google Scholar 

  38. Matsunaga T, Sasaki F, Ohira M, et al. Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma. Pediatr Surg Int. 2003;19:142–6.

    PubMed  Google Scholar 

  39. Fuchs J, Rydzynski J, von Schweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer. 2002;95:172–82.

    Article  PubMed  Google Scholar 

  40. Otte JB, Pritchard J, Aronson DC, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer. 2004;42:74–83.

    Article  PubMed  CAS  Google Scholar 

  41. von Schweinitz D. Identification of risk groups in hepatoblastoma-another step in optimising therapy. Eur J Cancer. 2000;36:1343–6.

    Article  Google Scholar 

  42. Haliloglu M, Hoffer FA, Gronemeyer SA, et al. 3D gadolinium-enhanced MRA: evaluation of hepatic vasculature in children with hepatoblastoma. J Magn Reson Imaging. 2000;11:65–8.

    Article  PubMed  CAS  Google Scholar 

  43. Hu J, Wills M, Baker BA, Perlman EJ. Comparative genomic hybridization analysis of hepatoblastomas. Genes Chromosomes Cancer. 2000;27:196–201.

    Article  PubMed  CAS  Google Scholar 

  44. Kairemo KJ, Lindahl H, Merenmies J, et al. Anti-alpha-fetoprotein imaging is useful for staging hepatoblastoma. Transplantation. 2002;73:1151–4.

    Article  PubMed  Google Scholar 

  45. Ohama K, Nagase H, Ogino K, et al. Alpha-fetoprotein (AFP) levels in normal children. Eur J Pediatr Surg. 1997;7:267–9.

    PubMed  CAS  Google Scholar 

  46. Schnater JM, Aronson DC, Plaschkes J et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer. 2002;94:1111–20.

    Article  PubMed  Google Scholar 

  47. Koneru B, Flye MW, Busuttil RW, et al. Liver transplantation for hepatoblastoma. The American experience. Ann Surg. 1991;213:118–21.

    Article  PubMed  CAS  Google Scholar 

  48. Reyes JD, Carr B, Dvorchik I, et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr. 2000;136:795–804.

    Article  PubMed  CAS  Google Scholar 

  49. Pimpalwar AP, Sharif K, Ramani P, et al. Strategy for hepatoblastoma management: Transplant versus nontransplant surgery. J Pediatr Surg. 2002: 240–5.

  50. Srinivasan P, McCall J, Pritchard J, et al. Orthotopic liver transplantation for unresectable hepatoblastoma. Transplantation. 2002;74:652–5.

    Article  PubMed  CAS  Google Scholar 

  51. Pritchard J, Brown J, Shafford E, et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach-results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol. 2000;18:3819–28.

    PubMed  CAS  Google Scholar 

  52. Chardot C, Saint Martin C, Gilles A, et al. Living-related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma. Transplantation. 2002;73:90–2.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unidad de Oncología Pediátrica, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046, Madrid, España

    Purificación García-Miguel

  2. Departamento de Cirugía Pediátrica. Unidad de Trasplantes Digestivos, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046, Madrid, España

    y Manuel López Santamaría

Authors
  1. Purificación García-Miguel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. y Manuel López Santamaría
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Purificación García-Miguel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

García-Miguel, P., Santamaría, y.M.L. Estado actual del diagnóstico y tratamiento del hepatoblastoma. Clin Transl Oncol 7, 328–334 (2005). https://doi.org/10.1007/BF02710274

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02710274

Search

Navigation